Clinton Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Clinton Group's AMGN Position: Q3 2018 in Review
Clinton Group increased its Amgen (AMGN) stake by 23% in Q3 2018, buying an estimated $902K and bringing the position to 24,547 shares worth $5.09M. The position accounts for 1.82% of the portfolio, ranked #12.
Clinton Group first reported a position in AMGN in Q3 2013 and has held it in 18 quarters since. The position peaked at $15.8M in Q2 2016. 1,796 funds tracked by Wall St. Rank hold AMGN as of Q3 2018.
- Clinton Group held 24,547 shares of Amgen worth $5.09M as of Q3 2018.
- Clinton Group bought 4,576 Amgen shares in Q3 2018, an estimated $902K.
- Amgen made up 1.82% of Clinton Group's portfolio in Q3 2018, its #12 holding.
- Clinton Group first reported a position in Amgen in Q3 2013 and has held it in 18 quarters since.
- Clinton Group's Amgen position peaked at $15.8M in Q2 2016.
- 1,796 funds tracked by Wall St. Rank held Amgen as of Q3 2018.
Based on Clinton Group's 13F filing for Q3 2018, filed 10 Oct 2018.